Angiotensin-Converting Enzyme 3D structures: Difference between revisions
Jump to navigation
Jump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 10: | Line 10: | ||
**[[2c6f]] – hANCE N domain<br /> | **[[2c6f]] – hANCE N domain<br /> | ||
**[[2x8y]] – DmANCE – Drosophila melanogaster<br /> | **[[2x8y]] – DmANCE – Drosophila melanogaster<br /> | ||
**[[6s1y]] – moANCE N domain - mosquito<br /> | |||
*Angiotensin Converting Enzyme N domain (1-641) complex | *Angiotensin Converting Enzyme N domain (1-641) complex | ||
**[[2c6n]], [[1o86]], [[4c2p]], [[2ydm]], [[1uze]], [[1uzf]], [[6h5x]] - hANCE + anti-hypertensive drug<br /> | **[[2c6n]], [[1o86]], [[4c2p]], [[2ydm]], [[1uze]], [[1uzf]], [[6h5x]] - hANCE + anti-hypertensive drug<br /> | ||
**[[6en5]], [[6en6]], [[4bzr]] - hANCE + inhibitor<br /> | **[[6en5]], [[6en6]], [[4bzr]], [[6tt4]] - hANCE + inhibitor<br /> | ||
**[[4bzs]] – hANCE (mutant) + inhibitor<br /> | **[[4bzs]], [[6tt3]] – hANCE (mutant) + inhibitor<br /> | ||
**[[6f9r]], [[6f9t]], [[6f9u]], [[6f9v]] - hANCE + chronic heart failure drug<br /> | **[[6f9r]], [[6f9t]], [[6f9u]], [[6f9v]] - hANCE + chronic heart failure drug<br /> | ||
**[[3kbh]], [[3d0g]], [[3d0h]], [[3d0i]], [[2ajf]], [[3sci]], [[3scj]], [[3sck]], [[3scl]], [[6cs2]], [[6acg]], [[6acj]], [[6ack]] – hANCE 2 +spike glycoprotein<br /> | **[[3kbh]], [[3d0g]], [[3d0h]], [[3d0i]], [[2ajf]], [[3sci]], [[3scj]], [[3sck]], [[3scl]], [[6cs2]], [[6acg]], [[6acj]], [[6ack]], [[6lzg]], [[6m0j]], [[6vw1]] – hANCE 2 + spike glycoprotein<br /> | ||
**[[4bxk]], [[4ca5]], [[4ca7]], [[4ca8]], [[2xy9]], [[2xyd]] – hANCE + phosphinic inhibitor<br /> | **[[4bxk]], [[4ca5]], [[4ca7]], [[4ca8]], [[2xy9]], [[2xyd]] – hANCE + phosphinic inhibitor<br /> | ||
**[[4ca6]] - hANCE N domain (mutant) + phosphinic inhibitor<br /> | **[[4ca6]], [[6tt1]] - hANCE N domain (mutant) + phosphinic inhibitor<br /> | ||
**[[4aph]] – hANCE + angiotensin II<br /> | **[[4aph]] – hANCE + angiotensin II<br /> | ||
**[[4apj]] – hANCE + bradykinin-potentiating peptide B<br /> | **[[4apj]], [[6qs1]] – hANCE + bradykinin-potentiating peptide B<br /> | ||
**[[1r42]], [[1r4l]] – hANCE + disordered segment of collectrin homology domain<br /> | **[[1r42]], [[1r4l]] – hANCE + disordered segment of collectrin homology domain<br /> | ||
**[[2xhm]] – DmANCE+K inhibitor<br /> | **[[2xhm]] – DmANCE+K inhibitor<br /> | ||
| Line 29: | Line 29: | ||
**[[4aa2]], [[4asr]] – DmANCE + bradykinin-potentiating peptide B<br /> | **[[4aa2]], [[4asr]] – DmANCE + bradykinin-potentiating peptide B<br /> | ||
**[[4asq]] – DmANCE + bradykinin peptide<br /> | **[[4asq]] – DmANCE + bradykinin peptide<br /> | ||
**[[6s1z]] – moANCE + fosinoprilat<br /> | |||
*Angiotensin Converting Enzyme C domain (642-1232) complex | *Angiotensin Converting Enzyme C domain (642-1232) complex | ||
| Line 36: | Line 37: | ||
**[[2oc2]], [[4ca5]], [[4ca7]], [[4ca8]] - hANCE+phosphinic inhibitor<br /> | **[[2oc2]], [[4ca5]], [[4ca7]], [[4ca8]] - hANCE+phosphinic inhibitor<br /> | ||
**[[6h5w]] - hANCE (mutant) + anti-hypertensive drug<br /> | **[[6h5w]] - hANCE (mutant) + anti-hypertensive drug<br /> | ||
*Angiotensin Converting Enzyme complex | |||
**[[6m1d]] – hANCE 2 + Na-dependent neutral amino acid transporter – Cryo EM<br /> | |||
**[[6m17]], [[6m18]] – hANCE 2 + Na-dependent neutral amino acid transporter + spike glycoprotein – Cryo EM<br /> | |||
}} | }} | ||
[[Category: Topic Page]] | [[Category: Topic Page]] | ||
Revision as of 13:29, 4 June 2020
3D Structures of Angiotensin-Converting Enzyme3D Structures of Angiotensin-Converting Enzyme
Updated on 04-June-2020